Natixis’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-63,900
Closed -$2.96M – 1004
2022
Q4
$2.96M Buy
+63,900
New +$2.77M 0.02% 472

Other funds holding BSX

Natixis's BSX Position: Q3 2026 in Review

Natixis reduced its Boston Scientific (BSX) stake by 16% in Q3 2026, selling an estimated $1.21M and leaving 141,846 shares worth $6.19M. The position accounts for 0.02% of the portfolio, ranked #444.

Natixis first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $74.7M in Q4 2021. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Natixis held 141,846 shares of Boston Scientific worth $6.19M as of Q3 2026.
  • Natixis sold 26,190 Boston Scientific shares in Q3 2026, an estimated $1.21M.
  • Boston Scientific made up 0.02% of Natixis's portfolio in Q3 2026, its #444 holding.
  • Natixis first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
  • Natixis's Boston Scientific position peaked at $74.7M in Q4 2021.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.